Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)

Organogenesis Holdings has reported Non-Current Debt over the past 8 years, most recently at $56.2 million for Q3 2024.

  • Quarterly results put Non-Current Debt at $56.2 million for Q3 2024, down 9.6% from a year ago — trailing twelve months through Sep 2024 was $56.2 million (down 9.6% YoY), and the annual figure for FY2023 was $60.7 million, down 8.28%.
  • Non-Current Debt for Q3 2024 was $56.2 million at Organogenesis Holdings, down from $57.7 million in the prior quarter.
  • Over the last five years, Non-Current Debt for ORGO hit a ceiling of $71.7 million in Q3 2021 and a floor of $10.0 million in Q1 2020.
  • Median Non-Current Debt over the past 5 years was $60.7 million (2023), compared with a mean of $52.2 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 79.85% in 2020 and later skyrocketed 607.69% in 2021.
  • Organogenesis Holdings' Non-Current Debt stood at $10.0 million in 2020, then skyrocketed by 607.69% to $70.8 million in 2021, then dropped by 6.41% to $66.2 million in 2022, then decreased by 8.28% to $60.7 million in 2023, then decreased by 7.56% to $56.2 million in 2024.
  • The last three reported values for Non-Current Debt were $56.2 million (Q3 2024), $57.7 million (Q2 2024), and $59.4 million (Q1 2024) per Business Quant data.